You are here: Industry Insights > COVID-19

News List

Last developments in epidemic control on March 12 (2) chinadaily
March 12, 2020
Here are the latest developments on the novel coronavirus disease (COVID-19) in China.
China says COVID-19 peak is over chinadaily
March 12, 2020
The peak of the current outbreak of novel coronavirus disease (COVID-19) in China is over, a spokesperson of the National Health Commission said on March 12.
Mount Sinai and Harbour BioMed collaborate to advance novel biotherapies to treat cancer and coronavirus COVID-19 pharmaceutical-business-review
March 12, 2020
Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted collaboration to develop novel, fully human antibodies for the treatment and prevention of various diseases including oncology and immunology.
Novavax secures CEPI funding for Covid-19 vaccine pharmaceutical-technology
March 12, 2020
Novavax has received initial funding of $4m from the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of a Covid-19 vaccine.
Sanofi and Regeneron to assess Kevzara to treat Covid-19 pharmaceutical-technology
March 12, 2020
Sanofi and Regeneron Pharmaceuticals have plans to initiate clinical trials of rheumatoid arthritis drug Kevzara for the treatment of Covid-19 symptoms.
CEL-SCI to develop Covid-19 immunotherapy pharmaceutical-technology
March 12, 2020
Biotechnology company CEL-SCI has begun efforts to develop an immunotherapy for the potential treatment of Covid-19 coronavirus infection.
Integral Molecular to work on coronavirus vaccine research pharmaceutical-technology
March 12, 2020
US-based biotechnology company Integral Molecular will leverage its technology platforms to identify Covid-19 vaccines and therapeutics.
Wellcome, Gates Foundation, Mastercard focus on Covid-19 therapies pharmaceutical-technology
March 12, 2020
Wellcome has partnered with the Bill & Melinda Gates Foundation and Mastercard to provide up to $125m of seed funding to accelerate the development of Covid-19 therapies.
Serum Institute plans COVID-19 vaccine by 2022 expresspharma
March 12, 2020
States the need for fast-tracking of regulatory clearances for the vaccine.
EU addresses potential impact of COVID-19 on medicines supply expresspharma
March 12, 2020
The mandate is to provide strategic leadership for urgent and coordinated action within the EU in case a crisis caused by major events.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page